Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FEED

ENvue Medical Inc

Feb 06 • 04:00PM ET

2.92

+0.05 1.74 %

Healthcare • Medical Devices • USA • NASD

Feb 04, 7:30 AMRecent U.S. distribution partnership with U-Deliver fuels premarket momentum for ENvue Medical.

Peers: INVA IRIX STXS OFIX PAVM LUNA MLSS ATEC ASMB MVIS

| Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-96.17	Insider Own	0.76%	Shs Outstand	1.09M	Perf Week	-9.60%
Market Cap	3.18M	Forward P/E	-	EPS next Y	-	Insider Trans	-26.10%	Shs Float	1.08M	Perf Month	29.78%
Enterprise Value	-2.63M	PEG	-	EPS next Q	-	Inst Own	21.40%	Short Float	19.84%	Perf Quarter	-39.67%
Income	-5.21M	P/S	1.18	EPS this Y	-	Inst Trans	-0.70%	Short Ratio	0.02	Perf Half Y	-64.96%
Sales	2.69M	P/B	0.07	EPS next Y	-	ROA	-11.79%	Short Interest	0.21M	Perf YTD	26.41%
Book/sh	42.00	P/C	0.46	EPS next 5Y	-	ROE	-15.71%	52W High	162.50 -98.20%	Perf Year	-94.15%
Cash/sh	6.41	P/FCF	-	EPS past 3/5Y	52.09% 40.47%	ROIC	-12.26%	52W Low	0.99 194.95%	Perf 3Y	-99.56%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	14.70% 37.00%	Gross Margin	30.02%	Volatility	33.98% 35.16%	Perf 5Y	-99.89%
Dividend TTM	-	EV/Sales	-0.98	EPS Y/Y TTM	29.19%	Oper. Margin	-351.77%	ATR (14)	0.80	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.67	Sales Y/Y TTM	-18.41%	Profit Margin	-193.89%	RSI (14)	55.13	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.86	EPS Q/Q	97.68%	SMA20	41.06%	Beta	2.21	Target Price	10.50
Payout	-	Debt/Eq	0.03	Sales Q/Q	92.02%	SMA50	1.74%	Rel Volume	0.22	Prev Close	2.87
Employees	31	LT Debt/Eq	0.00	Earnings	-	SMA200	-68.62%	Avg Volume	9.54M	Price	2.92
IPO	May 28, 2015	Option/Short	No / No	EPS/Sales Surpr.	- -	Trades		Volume	2,136,217	Change	1.74%

Jan-28-26 09:00AM	ENvue Medical Signs Strategic Partnership Agreement with U-Deliver for U.S. Distribution of Over-the-Counter Reusable ENFit Syringe Line (GlobeNewswire) +119.05%
08:31AM	EXCLUSIVE: ENvue Medical Pushes Reusable OTC Syringes Into Home Care With Distribution Deal (Benzinga)
Jan-21-26 08:30AM	ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial (GlobeNewswire)
Jan-14-26 08:30AM	ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription (GlobeNewswire) -26.72%
08:02AM	EXCLUSIVE: Micro-Cap ENvue Medical Launches OTC Reusable Syringes For Feeding, Medication Delivery (Benzinga)
09:10AM	Loading…
Jan-10-26 09:10AM	ENvue Medical announces launch of new development, integration program (TipRanks)
Jan-09-26 09:01AM	ENvue Medical Launches Program to Address Patient Pain and Discomfort with Indwelling Nasogastric Tubes Based on Previously Published, Peer-Reviewed Clinical Research (GlobeNewswire) -7.60%
Jan-08-26 10:02AM	ENvue Medical to Ring the Nasdaq Opening Bell on Wednesday, January 14th, 2026 (GlobeNewswire) +11.11%
Dec-15-25 09:00AM	ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman (Business Wire) -5.61%
Nov-19-25 08:00AM	NanoVibronix Issues Letter to Shareholders (Business Wire) -8.80%
Sep-18-25 08:00AM	NanoVibronix Launches "Oscar" Training Aid to Accelerate ENvue Adoption and Unlock New Revenue Opportunities (Business Wire)
Sep-16-25 03:57PM	NanoVibronix Announces Pricing of $2.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (Business Wire) -28.50%
Sep-15-25 08:00AM	NanoVibronix Announces Grant of New U.S. Patent Further Expanding ENvue Medical's Intellectual Property Portfolio (Business Wire) +64.87%
Sep-04-25 08:00AM	NanoVibronix Announces U.S. Patent Granted to ENvue Medical for Real-Time Imaging Overlay in Navigation Technology (Business Wire)
Aug-08-25 09:00AM	NanoVibronix Announces Reverse Stock Split (Business Wire)
09:00AM	Loading…
Jul-18-25 09:00AM	NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock (Business Wire)
Jun-26-25 08:00AM	NanoVibronix Announces ENvue Drive First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation (Business Wire)
Jun-24-25 08:00AM	NanoVibronixs ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue Navigation Systems for Enteral Feeding Tube Placement (Business Wire)
Jun-11-25 08:00AM	ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System (Business Wire) +47.51%
Jun-04-25 08:38AM	NanoVibronix Announces CEO Transition (Business Wire)
May-28-25 04:22PM	NanoVibronix Responds to False Post (Business Wire) -27.49% +46.10%
08:00AM	Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures (Business Wire)
May-16-25 04:30PM	NanoVibronix Announces Closing of $10 Million Public Offering of Preferred Stock and Warrants (Business Wire) -13.99% +5.69%
May-15-25 09:00AM	NanoVibronix Announces Pricing of $10 Million Public Offering of Preferred Stock and Warrants (Business Wire) -62.57%
May-12-25 08:50AM	NanoVibronix Announces Results from UroShield Case Series (Business Wire)
Apr-11-25 08:00AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Apr-01-25 08:00AM	NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia (Business Wire) -10.56%
Mar-21-25 06:36AM	Why Nanovibronix Inc. (NAOV) Surged On Thursday? (InsiderMonkey)
Mar-14-25 08:00AM	Successful Independent Study of the NanoVibronix UroShield Device Published in the Australian and New Zealand Continence Journal (Business Wire) -16.41%
Mar-12-25 08:00AM	NanoVibronix Announces Reverse Stock Split (Business Wire) -32.15%
09:43AM	Loading…
Feb-14-25 09:43AM	NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. (Business Wire) -5.58%
Jan-07-25 08:00AM	NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes (Business Wire) -18.30%
05:53AM	Transforming catheter care: NanoVibronix completes successful UroShield US trial (Medical Device Network)
Jan-06-25 11:16AM	NanoVibronix achieves goals of US trial pilot phase with UroShield (Medical Device Network) +16.47%
08:00AM	NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield at the University of Michigan (Business Wire)
Dec-11-24 08:00AM	NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement (Business Wire) -14.29%
Nov-12-24 08:00AM	NanoVibronix Provides Business Update (Business Wire) +5.97%
Oct-09-24 08:30AM	NanoVibronix Takes Next Step to Partner with Specialist Urology Company to Expand Sales of UroShield in Germany (Business Wire)
Sep-23-24 08:30AM	NanoVibronix Signs Letter of Intent with Potential New Distributor (Business Wire)
Aug-21-24 08:30AM	NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders (Business Wire)
May-22-24 08:30AM	NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan (Business Wire)
May-16-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
May-15-24 11:53PM	NAOV Stock Earnings: NanoVibronix Reported Results for Q1 2024 (InvestorPlace)
May-14-24 12:55PM	NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield (MT Newswires)
08:30AM	NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield (Business Wire)
May-03-24 07:31AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
May-01-24 08:00AM	NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs FSS Contract Award (Business Wire) -6.12%
Apr-29-24 09:00AM	Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-24-24 01:00PM	NanoVibronix to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 (ACCESSWIRE)
Apr-10-24 07:52AM	NAOV Stock Earnings: NanoVibronix Reported Results for Q4 2023 (InvestorPlace) -9.15%
Apr-09-24 08:30AM	NanoVibronix Issues Letter to Stockholders (Business Wire)
Mar-28-24 08:30AM	NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield (Business Wire)
Dec-06-23 09:00AM	NanoVibronix Featured in Your Bladder Health Magazine (Business Wire)
Dec-04-23 09:00AM	NanoVibronix Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity (Business Wire)
Nov-28-23 09:00AM	NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan (Business Wire) -13.87%
Nov-21-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire) +9.16%
Nov-14-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Nov-07-23 08:30AM	NanoVibronix UroShield Products Available on NHS Drug Tariff Effective November 1 (Business Wire)
Sep-27-23 08:00AM	NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire)
Sep-06-23 08:30AM	NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting (Business Wire) -8.48%
Aug-30-23 02:29PM	NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules (Business Wire) +67.59%
12:07PM	Why Is NanoVibronix Stock Trading Higher Today? (Benzinga)
08:30AM	NanoVibronix Cites Positive Results from Independent Testing of UroShield (Business Wire)
Aug-29-23 04:05PM	NanoVibronix Responds to CMS Determination for PainShield (Business Wire)
Aug-28-23 08:30AM	NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services Drug Tariff (Business Wire) -14.04%
Aug-23-23 08:45AM	NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus (Business Wire) -5.62%
Jun-14-23 08:30AM	NanoVibronix Announces Distribution Agreement with Sports Medicine Supplier Mio-Guard (Business Wire)
May-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Apr-18-23 08:30AM	NanoVibronix Issues Letter to Shareholders (Business Wire)
Mar-28-23 08:30AM	NanoVibronix Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services (CMS) (Business Wire)
Mar-21-23 08:30AM	NanoVibronix Files Provisional U.S. Patent Application for UroShield Ultra (Business Wire) +8.29%
Mar-14-23 09:15AM	NanoVibronix Announces Positive Results from Independent Product Trial of UroShield for Patients with a Spinal Cord Injury (Business Wire)
Mar-03-23 08:30AM	NanoVibronix Regains Nasdaq Compliance (Business Wire)
Feb-22-23 08:30AM	NanoVibronix to Launch Rental Program for PainShield and UroShield (Business Wire) +5.08%
Feb-08-23 12:00PM	NanoVibronix Announces Reverse Stock Split (Business Wire) -15.38%
Jan-18-23 08:30AM	NanoVibronix Provides Update on Expanding Access to PainShield (Business Wire) -7.57%
Dec-15-22 04:05PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today (Business Wire)
Dec-13-22 08:30AM	NanoVibronix Announces Partnership with Peak Medical, Ltd. (Business Wire)
Dec-09-22 06:11AM	Shareholders Will Likely Find NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Compensation Acceptable (Simply Wall St.)
Dec-01-22 02:06PM	NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire)
Nov-29-22 08:07AM	NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (Business Wire) -21.00%
Nov-28-22 03:18PM	NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus (Business Wire) +144.27%
Nov-17-22 06:23AM	NanoVibronix Third Quarter 2022 Earnings: US$0.034 loss per share (vs US$0.26 loss in 3Q 2021) (Simply Wall St.)
Nov-16-22 10:15AM	Interim Results Of NanoVibronix's Uroshield Show Beneficial Effects For Patients (Benzinga)
08:30AM	NanoVibronix Announces Interim Results of Clinical Study for UroShield (Business Wire)
Nov-15-22 08:33AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Oct-19-22 08:30AM	NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement (Business Wire)
Sep-23-22 08:30AM	NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract (Business Wire) +25.17%
Sep-14-22 04:05PM	NanoVibronix Sets Date for Annual Shareholder Meeting (Business Wire)
09:25AM	NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock (Business Wire)
Sep-02-22 04:30PM	NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing (Business Wire) -14.88%
Aug-18-22 11:30AM	NanoVibronix Provides Business Update in Letter to Shareholders (Business Wire)
Jul-25-22 08:30AM	Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely? (Simply Wall St.) -5.15%
Jul-12-22 08:30AM	NanoVibronix Announces Webinar Series to Promote UroShield (Business Wire)
Jun-29-22 08:30AM	NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability (Business Wire)
May-17-22 08:30AM	NanoVibronix Reports First Quarter 2022 Financial Results (Business Wire) +5.16%
May-04-22 08:30AM	NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS (Business Wire) +5.39%
Apr-25-22 08:30AM	NanoVibronix Adds Additional Product to Federal Supply Schedule (Business Wire) +7.40%
Apr-05-22 08:30AM	NanoVibronix Advances Efforts to Achieve NHS Approval (Business Wire) -7.63%
Mar-30-22 11:16AM	Health Canada Approves NanoVibronix's PainGuard, UroGuard As Licensed Devices (Benzinga) +22.64%

ENvue Medical, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
BANK OF AMERICA CORP /DE/	10% Owner	Feb 02 '26	Sale	3.05	2,918	8,906	231,138	Feb 04 09:03 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FEED

ENvue Medical Inc

Upgrade your FINVIZ experience